The global Aesthetic Medicine Market size is expected to reach USD 332.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.5% from 2022 to 2030. According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is a branch of medicine focused on satisfying the aesthetic desires and goals of patients. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Some key drivers of the market include the introduction of innovative aesthetic devices such as non-invasive aesthetic devices, a growing focus on physical appearance, and a rise in adoption among geriatric individuals.
Aesthetic medicine mainly includes invasive and
non-invasive procedures. Invasive procedures include breast augmentation,
liposuction, and nose reshaping while non-invasive procedures include popular
technology such as Botox injections, soft tissue fillers, and chemical peel.
The rise in the number of obesity cases in the U.S. has urged patients to opt
for aesthetic treatments in the country. In the Asia Pacific region, the rise
in the income level of the adult population in countries, such as China and
India, is expected to create lucrative growth opportunities for the market. The
region is also backed by South Korea, which is the hub of cosmetic surgeries.
The growing urge to look young and fit has increased
the demand for aesthetic treatment in developing countries. Aesthetic
procedures such as liposuction, nose reshaping, and Botox injections are
gaining consumer interest in countries such as India and South Korea. Adults
are paying attention to their physical appearance closely. This has increased
the demand for cosmetic surgeries, with Botox being one of the most popular
procedures preferred.
Related Press Release@ Aesthetic Medicine Market Report
Aesthetic Medicine Market Report
Highlights
- Based on procedure type, the non-invasive procedures segment
dominated the market in 2021 and is projected to maintain its lead
throughout the forecast period owing to its quick and accurate results,
along with the ease of usage compared to invasive procedures
- In the invasive procedures segment, breast augmentation and
liposuction are expected to witness significant growth over the forecast
period
- The Asia Pacific region is projected to register the fastest CAGR
of 10.9% during the forecast period. Countries such as South Korea and
India are expected to serve as key revenue pockets
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment